Literature DB >> 21480473

Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?

George B Segel1, William Simon, Marshall A Lichtman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21480473     DOI： 10.1002/pbc.23128

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


× No keyword cloud information.
  4 in total

1.  Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis.

Authors:  E Du; Monica Diez-Silva; Gregory J Kato; Ming Dao; Subra Suresh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

2.  Imaging flow cytometry documents incomplete resistance of human sickle F-cells to ex vivo hypoxia-induced sickling.

Authors:  Kleber Yotsumoto Fertrin; Eduard J van Beers; Leigh Samsel; Laurel G Mendelsohn; Rehan Saiyed; James S Nichols; David A Hepp; Christine A Brantner; Mathew P Daniels; J Philip McCoy; Gregory J Kato
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

3.  Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease.

Authors:  Poorya Hosseini; Sabia Z Abidi; E Du; Dimitrios P Papageorgiou; Youngwoon Choi; YongKeun Park; John M Higgins; Gregory J Kato; Subra Suresh; Ming Dao; Zahid Yaqoob; Peter T C So
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-10       Impact factor: 11.205

4.  Erythroid Adhesion Molecules in Sickle Cell Anaemia Infants: Insights Into Early Pathophysiology.

Authors:  Valentine Brousse; Yves Colin; Catia Pereira; Cecile Arnaud; Marie Helene Odièvre; Anne Boutemy; Corinne Guitton; Mariane de Montalembert; Claudine Lapouméroulie; Julien Picot; Caroline Le Van Kim; Wassim El Nemer
Journal:  EBioMedicine       Date:  2014-12-18       Impact factor: 8.143
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.